ZimVie, Zimmer Biomet's spine and dental spinoff company, cracked $1 billion in third-party revenue and is on track to see similar results in 2022.

A judge with the U.S. District Court of the District of Massachusetts awarded NuVasive $1.6 million in damages after finding a former employee of the devicemaker breached his noncompete and nonsolicitation clauses, Mondaq reported March 31.

Life Spine's latest FDA clearance and five more updates from spine medtech companies in the last week:

Many exciting innovations are being developed in the spine device industry, with smaller companies and startups aiming to break into a market dominated by medtech giants such as Medtronic, Stryker and Johnson & Johnson.

Five spine and orthopedic medtech companies completed or announced acquisitions in the first quarter of 2022.

Life Spine's sacroiliac joint fixation system, SImpact, received FDA clearance for posterior-oblique surgical approaches, the devicemaker said March 29.

The FDA granted nine orthopedic device approvals in February:

CFOs hold the top financial position in a company and are responsible for projecting the organization's financial standing as well as advising the CEO and board on strategic direction.

From the separation of its spine and dental businesses to its latest commercial product launch, here are four key developments from Zimmer Biomet in the first quarter:

France-based Spine Innovations reached a milestone with its lumbar disc replacement device, and it's setting its sights on the U.S. market.

Globus Medical co-founder Andrew Iott is among two new additions to Happe Spine's board of directors.

A $3.1 billion acquisition and four more developments from Stryker in the first quarter of 2022:

SeaSpine's NanoMetalene technology was implanted in its 50,000th case, the devicemaker said in a March 24 news release.

Intraoperative neuromonitoring company Assure Holdings hired two executives.

From new acquisitions to new leadership, here are seven developments from Medtronic in the first quarter of 2022:

Changes are afoot in the orthopedic device industry, as several medtech companies have appointed new CEOs in 2022.

The compensation of medtech leaders varies based on the company's size and market share. While some have a larger base salary, others have higher bonuses and stock option value. 

In the last week, two devicemakers have been named in spine and orthopedic lawsuits.

Since March 4, six spine and orthopedic devicemakers announced leadership moves.

The FDA granted 16 orthopedic device approvals in February: